NOIDA, India, Nov. 24,
2022 /PRNewswire/ -- According to a
new report published by UnivDatos Markets Insights, the
Human Microbiome Market was valued at more than
USD 380.6 million in 2020 and is
expected to grow at a CAGR of around 26.7% from 2022-2028.
The analysis has been segmented into Product Type (Probiotics,
Prebiotics, Diagnostic Tests, Drugs, Medical Foods, Supplements,
and Others); Application (Diagnostics and Therapeutics); Disease
(Obesity, Infectious Diseases, Cancer, Autoimmune Diseases,
Metabolic & Gastrointestinal Disorders, and Others);
Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and
Online Pharmacies)); Region/Country.
Click here to view the Report Description & TOC
The human microbiome market report has been aggregated
by collecting informative data on various dynamics such as market
drivers, restraints, and opportunities. This innovative report
makes use of several analyses to get a closer outlook on the human
microbiome market. The human microbiome market report offers a
detailed analysis of the latest industry developments and trending
factors in the market that are influencing the market growth.
Furthermore, this statistical market research repository examines
and estimates the human microbiome market at the global and
Request for Sample Pages
Human microbiome is a collection of microorganisms that live on
or within the human body. These microbiomes have shown a potential
role in healthcare owing to their multiple functions, including
enabling easy digestion, regulation of the immune system, and
production of vitamins.
Factors such as a surge in the incidence of lifestyle disorders,
rising expenditure on research and development activities, and the
increase in funding by the federal government are some of the
prominent factors that are positively influencing the market growth
Some of the major players operating in the market include
Enterome Biosciences SA, Yakult Honsha Co., 4D Pharma, Second
Genome, Seres Therapeutics, Vedanta Biosciences, Inc., AOBiome,
Microbiome Therapeutics LLC, and OptiBiotix HEALTH PLC.
The recent covid-19 pandemic has disrupted the world and has
brought a state of shock to the global economy. The global pandemic
has impacted the healthcare industry and has transformed the way
healthcare is delivered. The human microbiome market has been
significantly affected during these times owing to the delay in
elective surgeries during the pandemic.
The global human microbiome market report is studied thoroughly
with several aspects that would help stakeholders in making their
decisions more curated.
- Based on product type, the market is segmented into probiotics,
prebiotics, diagnostic tests, drugs, medical foods, supplements,
and others. The drugs segment is expected to grow with high CAGR
rates during the forecast period which is mainly attributed to the
rising number of human microbiome-based therapeutic products in
clinical trials along with increased funding to develop
microbiome-based medications. Apart from this, probiotics held a
significant share of the market owing to rising consumer demand and
- On the basis of application, the market is bifurcated into
diagnostics and therapeutics. The therapeutics segment held the
dominant share in the global market due to increased funding in
research and development for microbiome-based therapies,
technological advancements, and an increase in the prevalence of
- Based on the disease, the human microbiome market is segmented
into obesity, infectious diseases, cancer, autoimmune diseases,
metabolic & gastrointestinal disorders, and others. The
infectious disease segment is expected to witness high CAGR rates
during the forecast period. The surge in the incidence of
infections due to microbial dysbiosis, because of antibiotic
treatment, and the rising number of clinical trials for the
development of target-specific microbiome-based therapies are the
major factors propelling the growth of this segment during the
- Based on the distribution channel, the market is classified as
retail pharmacies, hospital pharmacies, and online pharmacies.
Online pharmacies are expected to register high CAGR rates due to
the rising number of internet users, widening access to online
services, and the rapid use of e-prescriptions in hospitals and
other healthcare settings.
Have a Look at the Chapters
Human Microbiome Market Geographical Segmentation
- North America (United States, Canada, and Rest of North America)
- Europe (Germany, United
Italy, France, and the Rest of Europe)
- Asia-Pacific (China, Japan,
India, and the Rest of
- Rest of the World
North America is anticipated to
grow at a substantial CAGR during the forecast period. The major
factors such as
The major players targeting the market include
- Enterome Biosciences SA
- Yakult Honsha Co.
- 4D Pharma
- Vedanta Biosciences, Inc.
- Seres Therapeutics
- Metabiomics Corp.
- Microbiome Therapeutics LLC
- Second Genome
- OptiBiotix HEALTH PLC
The degree of competition among prominent global companies has
been elaborated by analyzing several leading key players operating
worldwide. The specialist team of research analysts sheds light on
various traits such as global market competition, market share,
most recent industry advancements, innovative product launches,
partnerships, mergers, or acquisitions by leading companies in the
Human Microbiome market. The major players have been analyzed by
using research methodologies for getting insight views on global
Key questions resolved through this analytical market
research report include:
- What are the latest trends, new patterns, and technological
advancements in the human microbiome market?
- Which factors are influencing the human microbiome market over
the forecast period?
- What are the global challenges, threats, and risks in the human
- Which factors are propelling and restraining the human
- What are the demanding global regions of the human microbiome
- What will be the global market size in the upcoming years?
- What are the crucial market acquisition strategies and policies
applied by global companies?
We understand the requirement of different businesses, regions,
and countries, we offer customized reports as per your requirements
of business nature and geography. Please let us know If you have
any custom needs.
About UnivDatos Market Insights (UMI)
Browse Other Related Research Reports from UnivDatos Market
- Cancer Microbiome Sequencing Market
- Cancer Prevention Pharmaceuticals Market
- Nutritional Supplements Market
- Live Cell Imaging Market
- Probiotics Market
Human Microbiome Market Report Coverage
Accelerate at a CAGR of
North America, Europe,
APAC, Rest of World
North America to
Dominate the Global Human
United States, Canada,
Germany, United Kingdom, Spain, Italy, France, China, Japan, and
SA, Yakult Honsha Co., 4D Pharma, Second Genome, Seres
Therapeutics, Vedanta Biosciences, Inc., AOBiome, Microbiome
Therapeutics LLC, and OptiBiotix HEALTH PLC.
Market Trends, Drivers,
and Restraints; Revenue Estimation and Forecast; Segmentation
Analysis; Impact of COVID-19; Demand and Supply Side Analysis;
By Product Type; By
Application; By Disease; By Distribution Channel; By
About UnivDatos Market Insights
UnivDatos Market Insights (UMI) is a passionate market research
firm and a subsidiary of Universal Data Solutions. We believe in
delivering insights through Market Intelligence Reports, Customized
Business Research, and Primary Research. Our research studies are
spread across topics across the world, we cover markets in over 100
countries using smart research techniques and agile methodologies.
We offer in-depth studies, detailed analysis, and customized
reports that help shape winning business strategies for our
UnivDatos Market Insights
SOURCE UnivDatos Market Insights Pvt. Ltd.